Evaluation of Therapeutic Effect of 0.5 mg Colchicine and 5 mg Prednisolone on Oral Aphthae

NCT ID: NCT00723268

Last Updated: 2008-07-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE2

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether low doses of prednisolone, or colchicine are effective in the treatment of oral aphthae.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Treatment of recurrent aphthous stomatitis (RAS) remains, to date, empirical and non-specific. The main goals of therapy are to minimize pain and functional disabilities as well as decrease inflammatory reactions and frequency of recurrences.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Oral Aphthae

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Oral ulcers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Prednisolone

Group Type ACTIVE_COMPARATOR

Prednisolone

Intervention Type DRUG

5MG Prednisolone per day for 3 months

Colchicine

Group Type ACTIVE_COMPARATOR

Colchicine

Intervention Type DRUG

0.5 MG Colchicine per day for 3 months

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Prednisolone

5MG Prednisolone per day for 3 months

Intervention Type DRUG

Colchicine

0.5 MG Colchicine per day for 3 months

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Confirmation of clinical diagnosis of aphthae
* Having the experience of oral aphthae at least once in a month
* Two weeks wash out periods after the last treatment

Exclusion Criteria

* History of any systemic disease
* Using drugs which affect immune system
* Pregnancy and breast feeding
* Aphthous related syndromes
Minimum Eligible Age

15 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Tehran

OTHER

Sponsor Role collaborator

Mashhad University of Medical Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mashhad Dental Research Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mashhad Dental school

Mashhad, Khorasan Razavi, Iran

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Iran

Related Links

Access external resources that provide additional context or updates about the study.

http://www.mums.ac.ir/mcdr

Mashhad Dental Research Center

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

286293

Identifier Type: -

Identifier Source: secondary_id

286293

Identifier Type: -

Identifier Source: org_study_id